-The Business Standard Nobel Prize-winning economist Amartya Sen, who has just written An Uncertain Glory: India and its Contradictions with Jean Dreze, tells Mihir S Sharma that he doesn't understand why his book has received an angry reaction, or why he is being called anti-growth and pro-redistribution. * Is it startling to discover that you are being called a licence Raj socialist? It is very strange indeed. Perhaps some of this reaction is...

-The Pioneer BHAWANIPATNA (Bhubaneswar): The Palli Sabha of Tadijhola village in Trilochanpur Gram panchayat of Kalahandi held on Tuesday unanimously declared that the villagers would not allow mining in the Niyamgiri Hills. "Niyam Raja is our father and Niyamgiri hills, our mother. Hence, we will not allow Vedanta to snatch it from us," said every villagers of Tadijhola present in the meeting. Out of 22 voters of the village, 19 were present...

-The Business Standard 7 things you should know in the Bhagwati vs Sen slugfest Jagdish Bhagwati and Amartya Sen are the two Indian economists who are most respected for their work. Both have worked on a broad spectrum of issues, though Sen is best known for his work on public choice and development and Bhagwati for his work on trade. They are both liberal, neoclassical economists, who support deregulation and disapprove of...

-First Post While the six biggest political parties have chosen to ignore the order to come under the Right to Information Act, a handful of regional political parties have embraced it wholeheartedly. However, that won't force the bigger parties to change their ways any time soon. On 3 June, the Central Information Commission (CIC) declared the six national political parties, Congress, BJP, CPI, CPI (M), NCP and BSP, as public authorities. However, the...

-The Hindu That the Union Health Ministry takes critical decisions affecting a large number of people without any scientific basis does not portend well for public health in India. Neither the ban imposed on the oral anti-diabetes drug pioglitazone on June 18 nor its revocation a month later with a requirement that the medicine be sold with a boxed warning highlighting the adverse side-effect of bladder cancer was based on any...